Gastric cancer is the second most common cause of cancer-related deaths worldwide. There is growing evidence suggesting that cancer signaling networks are wired in a complex manner. This complexity is translated into poor clinical outcome, a common feature of gastric cancer. This wiring is not only important for maintaining cancer cell survival but also for providing supportive properties such as angiogenesis. The molecular targets that govern this interaction between the molecular signaling pathways that drive gastric tumorigenesis remain largely uncharacterized. Therefore, the identification of critical molecular targets, located at the hub of the signaling networks that bridge cancer signaling pathways, is a key step in understanding the biology of gastric cancer and improving our currently limited diagnostic, preventive, and therapeutic approaches. In the present proposal, we plan to pursue our novel finding that shows DARPP-32 at the interface of two key signaling pathways, NF-kB and STAT-3;thus playing a crucial role in the development and progression of the gastric tumorigenesis cascade. The proposal examines a novel hypothesis that transcription up-regulation of DARPP-32 by NF-kB connects cancer cell signaling pathways leading to activation of STAT3, thereby placing DARPP-32 as a bridge between two important signaling pathways amplifying their oncogenic signals promoting angiogenesis and tumorigenesis. We propose three specific aims to test our hypothesis.
The first aim will test the transcription regulation of DARPP-32 by NF-kB and examine the mechanisms by which DARPP-32 regulates STAT3 signaling. These studies will define the role of DARPP-32 as a bridge between two important oncogenic signaling pathways, NF-kB and STAT3.
In Aim 2, we will examine the biological outcome of the NF-kB - DARPP-32 - STAT3 axis, explore its role in regulating angiogenesis, and determine the therapeutic potential of targeting the DARPP-32 signaling axis.
The third aim, will determine the role of DARPP-32 in promoting gastric tumorigenesis using genetic mouse models of DARPP-32 overexpression and knockdown. We will also explore the histopathological and clinical significance of overexpression of NF-kB - DARPP-32 - STAT3 in fully annotated de-identified human gastric cancer tissue samples. Our studies are conceptually innovative and of critical significance given the fact that the overall 5-year survival for gastric cancer is only 20%. Upon completion of our studies, the results will have a significant impact on understanding the biology of gastric cancer affecting our diagnostic, prognostic, and possibly clinical management of this disease.

Public Health Relevance

Gastric cancer is one of the most prevalent cancers world-wide. In this proposal, we plan to characterize the molecular function(s) of DARPP-32, a frequently overexpressed gene in gastric cancer, in order to identify its biological, diagnostic, prognostic, and possibly therapeutic values.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01CA093999-13
Application #
8743185
Study Section
Clinical, Integrative and Molecular Gastroenterology Study Section (CIMG)
Program Officer
Yassin, Rihab R,
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Surgery
Type
Schools of Medicine
DUNS #
City
Nashville
State
TN
Country
United States
Zip Code
37212
Soutto, Mohammed; Peng, DunFa; Katsha, Ahmed et al. (2015) Activation of ?-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut 64:1028-39
Belkhiri, Abbes; El-Rifai, Wael (2014) 5-Methylcytosine hydroxylation-mediated LINE-1 hypomethylation: a novel mechanism of proto-oncogenes activation in colorectal cancer? Gut 63:538-9
Chen, Zheng; Saad, Rama; Jia, Peilin et al. (2013) Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer 119:1985-93
Zhu, Shoumin; Hong, Jun; Tripathi, Manish K et al. (2013) Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. Mol Cancer Res 11:86-94
Zhu, Shoumin; Belkhiri, Abbes; El-Rifai, Wael (2011) DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. Gastroenterology 141:1738-48.e1-2
Jackson, Kaya; Soutto, Mohammed; Peng, DunFa et al. (2011) Epigenetic silencing of somatostatin in gastric cancer. Dig Dis Sci 56:125-30
Vangamudi, Bhavatarini; Zhu, Shoumin; Soutto, Mohammed et al. (2011) Regulation of ?-catenin by t-DARPP in upper gastrointestinal cancer cells. Mol Cancer 10:32
Soutto, Mohammed; Belkhiri, Abbes; Piazuelo, M Blanca et al. (2011) Loss of TFF1 is associated with activation of NF-ýýB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest 121:1753-67
Schneider, Barbara G; Peng, Dun-Fa; Camargo, M Constanza et al. (2010) Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer 127:2588-97
Mukherjee, Kaushik; Peng, Dunfa; Brifkani, Zaid et al. (2010) Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. Surgery 148:354-63

Showing the most recent 10 out of 24 publications